Niedermeier, M., Hennessy, B. T., Knight, Z. A., Henneberg, M., Hu, J., Kurtova, A. V., . . . Burger, J. A. (2009). Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell–mediated drug resistance in chronic lymphocytic leukemia: A novel therapeutic approach. Blood.
Citação norma ChicagoNiedermeier, Matthias, et al. "Isoform-selective Phosphoinositide 3′-kinase Inhibitors Inhibit CXCR4 Signaling and Overcome Stromal Cell–mediated Drug Resistance in Chronic Lymphocytic Leukemia: A Novel Therapeutic Approach." Blood 2009.
Citação norma MLANiedermeier, Matthias, et al. "Isoform-selective Phosphoinositide 3′-kinase Inhibitors Inhibit CXCR4 Signaling and Overcome Stromal Cell–mediated Drug Resistance in Chronic Lymphocytic Leukemia: A Novel Therapeutic Approach." Blood 2009.